NICE's advice programmes consists of a range of products that are either based on NICE guidance or involve a critical assessment of relevant evidence. However, these products do not have the status of formal NICE guidance, and do not contain new NICE recommendations.
Summaries of the best available evidence to inform local NHS planning and decision-making, for selected new medicines, off-label use of licensed medicines and unlicensed medicines.
inform national commissioning decisions about medicines, for example by NHS England
provide information for healthcare professionals to inform their decision-making and support the development and updating of local formularies
help inform the public about a medicine and condition to help them make decisions about the medicine
provide information about an unlicensed medicine or off-label use of a licensed medicine that is being considered when there are no suitable alternatives licensed for that situation.
Find out more
Learn how we select topics and prepare the summaries.
Medtech innovation briefings (MIBs)
Objective information on
Find out more
IAPT assessment briefings
Improving Access to Psychological Therapies (IAPT) services provide evidence-based therapies to people with anxiety, depression and medically unexplained symptoms. We assess digitally enabled therapies which offer the potential to expand these services further.